-
Gene Therapy, DNA's Past, RNA's Future: The Golden Era
02 Apr 2024 16:41 GMT
… one of the founders of Human Genome Sciences, I take pride in being … therapy during the early 2000s. Human Genome Sciences built on the groundbreaking work … of biotech companies such as Human Genome Sciences, Genzyme Corporation, Sangamo Therapeutics, and …
-
NeoImmuneTech Names New CEO
02 Apr 2024 14:08 GMT
… organizations such as Mallinckrodt Pharmaceuticals, Human Genome Sciences, and Vertex Pharmaceuticals. Oh has …
-
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer
02 Apr 2024 11:32 GMT
… organizations such as Mallinckrodt Pharmaceuticals, Human Genome Sciences, and Vertex Pharmaceuticals. Dr. Oh …
-
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
28 Mar 2024 16:05 GMT
… senior leadership roles at Medivation, Human Genome Sciences, Genentech, and Centocor. She received …
-
Morphic Therapeutic Taps Simon Cooper as Chief Medical Officer
19 Mar 2024 21:20 GMT
… Research, Napp Pharmaceutical Research, Roche, Human Genome Sciences and MedImmune.
Cooper holds a …
-
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
19 Mar 2024 12:00 GMT
… Research, Napp Pharmaceutical Research, Roche, Human Genome Sciences and MedImmune. Dr Cooper holds …
-
Human Genome Sciences Raises $100 Million from Private Offering
21 Sep 2019 11:05 GMT
… adjustment in certain circumstances.
Human Genome Sciences plans to use the … facility.
General corporate purposes.
Human Genome Sciences develops pharmaceutical products to … William A. Haseltine, CEO, Human Genome Sciences, 9410 Key West Ave., Rockville …
-
On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
26 Feb 2024 22:57 GMT
… biology background, having worked at Human Genome Sciences earlier in his career. Masoud …